Status:
RECRUITING
Aimmune Longitudinal Collaboration Study
Lead Sponsor:
Aimmune Therapeutics, Inc.
Conditions:
Stool Spore Colony Forming Units
Microbiome Composition
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
This study will include healthy households around the Irvine, CA area (based local to employees) and Tempe, AZ and Philadelphia, PA sites that will be instructed to take a daily fiber supplement (2.5 ...
Detailed Description
Participants will be either selected from a pool of previously screened and identified candidates or who have communicated interest in participating in research through GoodNature Program, run by Aimm...
Eligibility Criteria
Inclusion
- 18 years of age or greater
- Able to sign informed consent in English
- Households (2 or more adults) or individuals who are willing to provide a minimum of 3 separate stool samples per week and utilize a manual stool sampling tool. Alternatively, participants who can come to a collection site and leave stool samples a minimum of 3 days per week throughout the duration of the study.
- Are generally healthy
- Agreeable to adding chia seeds to diet
- Have access to a smartphone
Exclusion
- Less than 18 years of age
- Greater than 50 years of age
- Unable to provide a minimum of 3 stool samples per week
- Active donors for a commercial product
- Anyone who previously made a lot of a finished product
- Diagnosed with a digestive, intestinal, or other condition that contraindicates consuming a daily serving size of chia seeds (\~2.5 tbsp).
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT07218640
Start Date
October 1 2025
End Date
July 1 2026
Last Update
October 20 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Aimmune Therapeutics Manufacturing
Ambler, Pennsylvania, United States, 19002
2
GoodNature Tempe
Ambler, Pennsylvania, United States, 19002